FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010476225> ?p ?o ?g. }

• W3010476225 abstract "Objective: To investigate the role of Intravitreal Bevacizumab (IVB), in preventing vitreo-retinal complications in patients of Eale’s Disease (ED).Methods: This randomized control trial was conducted at Armed Forces Institute of Ophthalmology (AFIO), Rawalpindi from May 2015 to December 2016. A total of 52 eyes of 26 patients, diagnosed with stage I or II of ED were randomly divided in two groups. Group A received monthly injections of IVB for 3 months, with steroids and laser photocoagulation. Group B received only steroids and laser treatment. Patients were followed for three months, and were analyzed for different clinical parameters.Results: Mean age of study population was 28.5±2.64 years. Difference in frequency of patients requiring PPV and showing regression in neovascularization was statistically significant between both groups (p=0.005 for both). However, difference in frequency of patients showing progression in stage of ED, regression of vasculitis and best corrected visual acuity at 12 weeks between two groups was not statistically significant (p= 0.012, 0.579, 0.046 respectively).Conclusion: Intravitreal Bevacizumab injection, given monthly in patients of ED results in significantly more regression in neovascularization, and less requirement for PPV, as compared to those receiving standard steroids and laser photocoagulation treatment.doi: https://doi.org/10.12669/pjms.342.14483How to cite this:Mehboob MA, Tahir M, Batool H. Role of intravitreal bevacizumab in management of Eale’s Disease. Pak J Med Sci. 2018;34(2):-333-337. doi: https://doi.org/10.12669/pjms.342.14483This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited." @default.
• W3010476225 created "2020-03-13" @default.
• W3010476225 creator A5000063908 @default.
• W3010476225 creator A5012549954 @default.
• W3010476225 creator A5015007018 @default.
• W3010476225 date "2018-04-05" @default.
• W3010476225 modified "2023-10-16" @default.
• W3010476225 title "Role of intravitreal bevacizumab in management of Eale’s Disease" @default.
• W3010476225 cites W1593131166 @default.
• W3010476225 cites W1986641313 @default.
• W3010476225 cites W2019811354 @default.
• W3010476225 cites W2029904815 @default.
• W3010476225 cites W2036894837 @default.
• W3010476225 cites W2037069497 @default.
• W3010476225 cites W2059445839 @default.
• W3010476225 cites W2062661688 @default.
• W3010476225 cites W2070155141 @default.
• W3010476225 cites W2079825484 @default.
• W3010476225 cites W2089351050 @default.
• W3010476225 cites W2092385756 @default.
• W3010476225 cites W2153127461 @default.
• W3010476225 cites W2319661194 @default.
• W3010476225 cites W2332122433 @default.
• W3010476225 cites W2354928438 @default.
• W3010476225 cites W2521753039 @default.
• W3010476225 cites W2608243815 @default.
• W3010476225 cites W4292810416 @default.
• W3010476225 doi "https://doi.org/10.12669/pjms.342.14483" @default.
• W3010476225 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5954374" @default.
• W3010476225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29805403" @default.
• W3010476225 hasPublicationYear "2018" @default.
• W3010476225 type Work @default.
• W3010476225 sameAs 3010476225 @default.
• W3010476225 citedByCount "3" @default.
• W3010476225 countsByYear W30104762252022 @default.
• W3010476225 countsByYear W30104762252023 @default.
• W3010476225 crossrefType "journal-article" @default.
• W3010476225 hasAuthorship W3010476225A5000063908 @default.
• W3010476225 hasAuthorship W3010476225A5012549954 @default.
• W3010476225 hasAuthorship W3010476225A5015007018 @default.
• W3010476225 hasBestOaLocation W30104762251 @default.
• W3010476225 hasConcept C118487528 @default.
• W3010476225 hasConcept C126322002 @default.
• W3010476225 hasConcept C141071460 @default.
• W3010476225 hasConcept C2776015282 @default.
• W3010476225 hasConcept C2776694085 @default.
• W3010476225 hasConcept C2777802072 @default.
• W3010476225 hasConcept C2778257484 @default.
• W3010476225 hasConcept C2778328719 @default.
• W3010476225 hasConcept C2779134260 @default.
• W3010476225 hasConcept C71924100 @default.
• W3010476225 hasConceptScore W3010476225C118487528 @default.
• W3010476225 hasConceptScore W3010476225C126322002 @default.
• W3010476225 hasConceptScore W3010476225C141071460 @default.
• W3010476225 hasConceptScore W3010476225C2776015282 @default.
• W3010476225 hasConceptScore W3010476225C2776694085 @default.
• W3010476225 hasConceptScore W3010476225C2777802072 @default.
• W3010476225 hasConceptScore W3010476225C2778257484 @default.
• W3010476225 hasConceptScore W3010476225C2778328719 @default.
• W3010476225 hasConceptScore W3010476225C2779134260 @default.
• W3010476225 hasConceptScore W3010476225C71924100 @default.
• W3010476225 hasIssue "2" @default.
• W3010476225 hasLocation W30104762251 @default.
• W3010476225 hasLocation W30104762252 @default.
• W3010476225 hasLocation W30104762253 @default.
• W3010476225 hasLocation W30104762254 @default.
• W3010476225 hasOpenAccess W3010476225 @default.
• W3010476225 hasPrimaryLocation W30104762251 @default.
• W3010476225 hasRelatedWork W1668980245 @default.
• W3010476225 hasRelatedWork W1737347230 @default.
• W3010476225 hasRelatedWork W1995044506 @default.
• W3010476225 hasRelatedWork W2042956061 @default.
• W3010476225 hasRelatedWork W2065629733 @default.
• W3010476225 hasRelatedWork W2105729883 @default.
• W3010476225 hasRelatedWork W2162581351 @default.
• W3010476225 hasRelatedWork W2348628890 @default.
• W3010476225 hasRelatedWork W3063310417 @default.
• W3010476225 hasRelatedWork W4225968295 @default.
• W3010476225 hasVolume "34" @default.
• W3010476225 isParatext "false" @default.
• W3010476225 isRetracted "false" @default.
• W3010476225 magId "3010476225" @default.
• W3010476225 workType "article" @default.